Senescent Tumor Cells Build a Cytokine Shield in Colorectal Cancer

Area of Science:

• Oncology
• Immunology
• Cell Biology

Background:

• Cellular senescence plays a dual role in cancer progression, potentially supporting or inhibiting tumor growth.
• Understanding the interaction between senescent cells and the tumor microenvironment is crucial for developing effective cancer therapies.

Purpose of the Study:

• To investigate the relationship between senescent tumor cells and CD8+ T cell infiltration in colorectal cancer (CRC).
• To elucidate the mechanisms by which senescent tumor cells influence the immune microenvironment and impact immunotherapy response.

Main Methods:

• Analysis of gene expression in senescent tumor cells from colorectal cancer.
• Assessment of CD8+ T cell infiltration and its association with senescent cell proportion.
• In vivo studies involving neutralization of CXCL12/CSF1 and anti-PD1 therapy in allograft and AOM/DSS-induced CRC models.

Main Results:

• A negative association was observed between intratumoral CD8+ T cells and senescent tumor cells in CRC.
• Senescent tumor cells secrete CXCL12, impairing T cell migration, and CSF1, promoting M2 macrophage differentiation.
• Neutralization of CXCL12/CSF1 enhanced anti-PD1 efficacy and reduced tumor burden in preclinical models.

Conclusions:

• Senescent tumor cells establish a 'cytokine barrier' that protects non-senescent tumor cells from immune surveillance.
• Targeting senescent cell-derived CXCL12 and CSF1 presents a promising strategy to overcome immunotherapy resistance in colorectal cancer.